POSCO BIOVENTURES

posco-bioventures-logo

POSCO BioVentures' primary investment focus is on companies with novel, proprietary bio-molecules. POSCO BioVentures expects that 70% of its investments will be in companies focused on novel proprietary bio-molecules, with the balance of the investments in other enabling technologies.

#People #Financial #More

POSCO BIOVENTURES

Founded:
2002-01-01

Status:
Active

Email Addresses:
[email protected]

Technology used in webpage:
Domain Not Resolving


Current Employees Featured

not_available_image

Leo Kim
Leo Kim Chief Executive Officer @ POSCO BioVentures
Chief Executive Officer
2002-01-01

not_available_image

Virinia Hallner
Virinia Hallner Director o Finance @ POSCO BioVentures
Director o Finance

Investments List

Date Company Article Money raised
2011-01-03 Accera POSCO BioVentures investment in Series D - Accera 11 M USD
2010-03-30 TransMedics POSCO BioVentures investment in Series E - TransMedics 36 M USD
2010-03-08 Pulmonx POSCO BioVentures investment in Series C - Pulmonx 32 M USD
2008-11-12 Accera POSCO BioVentures investment in Series C - Accera 35 M USD
2007-04-13 TransMedics POSCO BioVentures investment in Series D - TransMedics 25.5 M USD
2006-03-14 TransMedics POSCO BioVentures investment in Series C - TransMedics 29.75 M USD
2006-01-01 ProteinSimple POSCO BioVentures investment in Series B - ProteinSimple 27 M USD
2005-01-18 GeneOhm Sciences POSCO BioVentures investment in Series C - GeneOhm Sciences 14 M USD
2004-09-16 Accera POSCO BioVentures investment in Series A - Accera 6 M USD
2004-06-23 PTC Therapeutics POSCO BioVentures investment in Series E - PTC Therapeutics 15 M USD

More informations about "POSCO BioVentures" on Search Engine